Zoetis | ZTS - Cash And Equivalent




Zoetis reported $1.99B in Cash and Equivalent for its fiscal quarter ending in December of 2024.

Cash And Equivalent Change Date
AbbVie USD 7.26B 5.87B Sep/2024
Align Technology USD 1.04B 1.95M Dec/2024
Bayer EUR 4.62B 731M Sep/2024
Bristol-Myers Squibb USD 10.35B 2.46B Dec/2024
Charles River Laboratories USD 194.61M 15.56M Dec/2024
Dentsply International USD 296M 17M Sep/2024
Eli Lilly USD 3.37B 145.4M Sep/2024
Henry Schein USD 126M 12M Sep/2024
Idexx Laboratories USD 288.27M 20.37M Dec/2024
Illumina USD 1.13B 258M Dec/2024
IQVIA Holdings USD 1.7B 130M Dec/2024
J&J USD 4.85B 20.03B Sep/2024
Laboratory Of America USD 1.52B 1.4M Dec/2024
Merck USD 14.59B 3.29B Sep/2024
Neogen USD 140.23M 19.75M Nov/2024
Pacira USD 245.96M 1.08M Sep/2024
Patterson Companies USD 157.94M 0 Oct/2024
Perrigo USD 1.46B 920.7M Sep/2024
Pfizer USD 1.09B 40M Sep/2024
Quest Diagnostics USD 549M 215M Dec/2024
Sanofi 6.8B 1.92B Jun/2024
Sanofi 6.8B 1.92B Jun/2024
Zoetis USD 1.99B 273M Dec/2024